Meningeal macrophages protect against viral neuroinfection

Julie Rebejac1, Elisa Eme-Scolan2, Laurie Arnaud Paroutaud1

  • 1Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, Marseille, France.

Immunity
|November 2, 2022
PubMed

Insights

Meningeal macrophages (MMs) protect the central nervous system from viral infections. Depleting these immune cells leads to severe meningitis, highlighting their crucial role in CNS viral defense.

Area of Science:

  • Neuroimmunology
  • Virology
  • Cellular Biology

Background:

  • The central nervous system (CNS) surface is protected by meninges housing meningeal macrophages (MMs).
  • MMs exhibit distinct phenotypes (MHC-II- vs. MHC-II+) that change with age and in response to stimuli.
  • The role of MMs in CNS viral infections is not fully understood.

Purpose of the Study:

  • To investigate the function of tissue-resident MMs in protecting the CNS against viral infections.
  • To determine the impact of MM depletion or dysfunction on viral spread and disease severity.
  • To explore potential therapeutic strategies targeting MMs for CNS viral diseases.

Main Methods:

  • Analysis of MHC-II expression on MMs in neonatal and adult mice.
  • In vivo challenge models using LPS, SARS-CoV-2, and lymphocytic choriomeningitis virus (LCMV).
  • Genetic manipulation (Stat1/Ifnar deletion) and pharmacological depletion of MMs.
  • Assessment of viral load, CNS infiltration, and disease outcomes.

Main Results:

  • Peripheral viral infections (LCMV) caused transient meningeal infection and activation.
  • Mice lacking MMs or with impaired Stat1/Ifnar signaling showed extensive viral spread into the CNS.
  • Local MM depletion resulted in meningeal infection and fatal meningitis.
  • Lower MHC-II+ MM numbers correlated with increased viral load.

Conclusions:

  • Meningeal macrophages are critical for preventing viral entry and spread into the CNS.
  • MMs act as a crucial barrier defense against viral pathogens.
  • MMs represent a potential therapeutic target for managing CNS viral infections.